Eye Health Becomes a Growing Global Concern in the Screen-Centric Era

As digital devices become deeply integrated into everyday life, eye health is emerging as a significant public health concern worldwide. Extended screen exposure, environmental pollution, changing lifestyles, and aging populations are contributing to a rising prevalence of dry eye syndrome (DES), a condition that occurs when the eyes fail to produce sufficient tears or when tears evaporate too quickly.

Dry eye syndrome can significantly impact quality of life, causing symptoms such as irritation, redness, blurred vision, burning sensations, and eye fatigue. The condition affects millions of people globally and is becoming increasingly common among both younger and older populations.

Growing awareness of eye health, advancements in ophthalmic treatments, and increasing access to specialized eye care services are supporting the expansion of the dry eye syndrome market.

The global dry eye syndrome market size was valued at USD 7.81 billion in 2025 and is projected to grow from USD 8.35 billion in 2026 to USD 14.25 billion by 2034 at a CAGR of 6.92% during the forecast period 2026–2034.

The rising incidence of ocular disorders, coupled with increasing demand for innovative treatment options, is expected to drive sustained market growth through the forecast period.

For Detailed Insights, Visit:

https://straitsresearch.com/report/dry-eye-syndrome-market

Screen Time Is Reshaping Eye Care Demand

The widespread use of smartphones, computers, tablets, and digital displays has dramatically altered visual habits across the globe.

Prolonged screen exposure often reduces blinking frequency, leading to faster tear evaporation and increased eye strain. As remote work, online education, gaming, and digital entertainment continue to expand, healthcare providers are witnessing a growing number of patients seeking treatment for dry eye symptoms.

This trend is particularly noticeable among younger consumers who spend significant portions of their day interacting with digital devices.

Key Factors Supporting Market Expansion

Aging Global Population

Older adults are more susceptible to dry eye syndrome due to age-related changes in tear production and ocular surface health.

As populations continue to age across North America, Europe, and parts of Asia-Pacific, the number of individuals requiring dry eye treatment is expected to increase substantially.

Rising Prevalence of Chronic Diseases

Medical conditions such as diabetes, rheumatoid arthritis, thyroid disorders, and autoimmune diseases can contribute to dry eye syndrome.

The growing burden of these chronic health conditions is creating additional demand for ophthalmic therapies and long-term disease management solutions.

Increasing Awareness and Diagnosis Rates

Public health campaigns, routine eye examinations, and improved access to ophthalmology services are helping identify more cases of dry eye syndrome.

Earlier diagnosis allows patients to receive timely treatment, supporting overall market growth.

Innovation Is Transforming Treatment Approaches

Advanced Prescription Therapies

Pharmaceutical companies are developing targeted therapies designed to address inflammation and improve tear production.

These treatments are helping physicians move beyond symptom management toward addressing underlying disease mechanisms.

Artificial Tears Continue to Evolve

Manufacturers are introducing next-generation lubricating eye drops with improved formulations that provide longer-lasting relief and enhanced comfort.

Preservative-free products are also gaining popularity among patients requiring frequent use.

Biologic and Regenerative Treatments

Emerging therapies involving biologics, regenerative medicine, and advanced ocular surface treatments are attracting increasing research and investment activity.

These innovations have the potential to significantly improve treatment outcomes for patients with severe forms of dry eye syndrome.

Expanding Treatment Landscape

Retail and Over-the-Counter Products

Artificial tears and lubricating eye drops remain among the most widely used treatment options due to their accessibility and affordability.

Prescription Medications

Prescription therapies continue to gain market share as healthcare providers seek more effective solutions for moderate-to-severe dry eye conditions.

Specialty Eye Care Clinics

The expansion of dedicated ophthalmology and vision care centers is improving patient access to advanced diagnostics and treatment services.

Teleophthalmology Services

Digital healthcare platforms are helping patients access eye care consultations remotely, improving treatment accessibility and convenience.

Challenges Facing Industry Participants

Underdiagnosis Remains Common

Many individuals experiencing mild symptoms fail to seek medical attention, resulting in delayed diagnosis and treatment.

Treatment Costs

Advanced therapies and long-term treatment regimens can create financial burdens for certain patient populations.

Variable Treatment Response

Patients often respond differently to available therapies, requiring personalized treatment strategies and ongoing clinical management.

Regulatory and Clinical Development Hurdles

Developing innovative ophthalmic therapies requires extensive clinical testing and regulatory approvals, which can increase development timelines and costs.

Regional Market Dynamics

North America Leads Global Adoption

North America remains a dominant market due to high awareness levels, advanced healthcare infrastructure, and strong adoption of innovative ophthalmic treatments.

Europe Benefits from Aging Demographics

European countries continue to experience increasing demand for eye care services driven by aging populations and rising prevalence of ocular disorders.

Asia-Pacific Emerges as a Fast-Growing Region

Growing healthcare investments, expanding middle-class populations, and increasing screen exposure are contributing to strong market growth throughout Asia-Pacific.

Middle East and Latin America Expand Healthcare Access

Improving healthcare infrastructure and rising awareness of eye health are creating new opportunities across emerging markets.

Future Outlook

The dry eye syndrome market is expected to witness sustained growth through 2034 as digital lifestyles, demographic shifts, and healthcare advancements continue to influence eye health trends. Increasing screen usage, aging populations, and growing awareness of ocular wellness are likely to remain key market drivers.

Manufacturers and healthcare providers that focus on innovative therapies, patient education, and improved treatment accessibility will be well-positioned to capitalize on future opportunities. As eye health becomes a larger component of preventive healthcare strategies, the demand for dry eye syndrome treatments is expected to remain strong across global markets.

Competitive Landscape

Major companies operating in the market include:

• AbbVie Inc.

• Alcon Inc.

• Bausch + Lomb Corporation

• Johnson & Johnson Vision

• Novartis AG

• Santen Pharmaceutical Co., Ltd.

• Sun Pharmaceutical Industries Ltd.

• Oasis Medical Inc.

• OCuSOFT Inc.

• Thea Pharma Inc.

Related Insights

Ophthalmic Drugs Market

https://straitsresearch.com/report/ophthalmic-drugs-market

Vision Care Market

https://straitsresearch.com/report/vision-care-market

About Us

Straits Research is a leading market intelligence and consulting organization specializing in market research, business forecasting, competitive intelligence, and strategic advisory services. The company delivers actionable insights that help organizations identify emerging opportunities and make informed business decisions across global industries.

Contact Us

Email: sales@straitsresearch.com

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)